| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,663 |
3,569 |
$166K |
| 87428 |
|
1,568 |
1,528 |
$88K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
768 |
738 |
$79K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
368 |
350 |
$51K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
258 |
251 |
$16K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
339 |
336 |
$11K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
793 |
775 |
$8K |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
82 |
74 |
$1K |
| 81025 |
|
249 |
246 |
$1K |
| 81002 |
|
286 |
282 |
$589.41 |
| 87210 |
|
84 |
83 |
$276.63 |